AstraZeneca Canada Inc. v. Canada (Minister of Health) et al.

JurisdictionFederal Jurisdiction (Canada)
CourtFederal Court (Canada)
JudgePhelan, J.
Citation2005 FC 189,2005 FC 648,[2005] F.T.R. Uned. B37
Date09 May 2005
Subject MatterCROWN

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex
14 practice notes
  • Merck Frosst Canada Ltd. v. Canada (Minister of Health), (2012) 426 N.R. 200 (SCC)
    • Canada
    • Supreme Court (Canada)
    • November 12, 2010
    ...F.C. 265; 86 N.R. 186 (F.C.A.), refd to. [para. 89]. AtraZeneca Canada Inc. v. Canada (Minister of Health) et al. (2005), 275 F.T.R. 133; 2005 FC 189, supplementary reasons [2005] F.T.R. Uned. B37; 2005 FC 648, affd. (2006), 353 N.R. 84; 2006 FCA 241, refd to. [para. Information Commissione......
  • Merck Frosst Canada Ltd. v. Canada (Minister of Health)
    • Canada
    • Supreme Court (Canada)
    • November 12, 2010
    ...265 ; 86 N.R. 186 (F.C.A.), refd to. [para. 89]. AtraZeneca Canada Inc. v. Canada (Minister of Health) et al. (2005), 275 F.T.R. 133 ; 2005 FC 189, supplementary reasons [2005] F.T.R. Uned. B37 ; 2005 FC 648 , affd. (2006), 353 N.R. 84 ; 2006 FCA 241 , refd to. [para. Information Com......
  • Table of cases
    • Canada
    • Irwin Books Information and Privacy Law in Canada
    • June 25, 2020
    ...#2006-330, 2006 CanLII 29532 (PCC) ...................................... 336 AstraZeneca Canada Inc v Canada (Minister of Health), 2005 FC 189 ......................................................................................... 194, 199 AT v Globe24h.com, 2017 FC 114 .......................
  • Access to Information in the Public Sector
    • Canada
    • Irwin Books Information and Privacy Law in Canada
    • June 25, 2020
    ...at para 109, quoting from the Health Canada Guidelines referred to with approval in AstraZeneca Canada Inc v Canada (Minister of Health) , 2005 FC 189 at para 64 [ AstraZeneca ]. 334 Merck Frosst , above note 137 at para 116. 335 Ibid at para 118. 336 Ibid at para 122. See also AstraZeneca ......
  • Get Started for Free
12 cases
  • Merck Frosst Canada Ltd. v. Canada (Minister of Health), (2012) 426 N.R. 200 (SCC)
    • Canada
    • Supreme Court (Canada)
    • November 12, 2010
    ...F.C. 265; 86 N.R. 186 (F.C.A.), refd to. [para. 89]. AtraZeneca Canada Inc. v. Canada (Minister of Health) et al. (2005), 275 F.T.R. 133; 2005 FC 189, supplementary reasons [2005] F.T.R. Uned. B37; 2005 FC 648, affd. (2006), 353 N.R. 84; 2006 FCA 241, refd to. [para. Information Commissione......
  • Merck Frosst Canada Ltd. v. Canada (Minister of Health)
    • Canada
    • Supreme Court (Canada)
    • November 12, 2010
    ...265 ; 86 N.R. 186 (F.C.A.), refd to. [para. 89]. AtraZeneca Canada Inc. v. Canada (Minister of Health) et al. (2005), 275 F.T.R. 133 ; 2005 FC 189, supplementary reasons [2005] F.T.R. Uned. B37 ; 2005 FC 648 , affd. (2006), 353 N.R. 84 ; 2006 FCA 241 , refd to. [para. Information Com......
  • Medavie v. PNB (Department of Health)
    • Canada
    • Court of Queen's Bench of New Brunswick (Canada)
    • July 3, 2018
    ...appears in many places in the jurisprudence relating to the exemptions: see, e.g., AstraZeneca Canada Inc. v. Canada (Minister of Health), 2005 FC 189 (CanLII) (with supplementary reasons at 2005 FC 648 (CanLII)), at para. 52, aff’d 2006 FCA 241, 353 N.R. 84, and Canada (Information Commiss......
  • Minister of Citizens' Services (B.C.) v. Information and Privacy Commissioner (B.C.) et al.
    • Canada
    • Supreme Court of British Columbia (Canada)
    • June 14, 2012
    ...in many places in the jurisprudence relating to the exemptions: see, e.g., AstraZeneca Canada Inc. v. Canada (Minister of Health) , 2005 FC 189 (CanLII) (with supplementary reasons at 2005 FC 648 (CanLII)), at para. 52, aff'd 2006 FCA 241, 353 N.R. 84, and Canada (Information Commissioner) ......
  • Get Started for Free
2 books & journal articles
  • Table of cases
    • Canada
    • Irwin Books Information and Privacy Law in Canada
    • June 25, 2020
    ...#2006-330, 2006 CanLII 29532 (PCC) ...................................... 336 AstraZeneca Canada Inc v Canada (Minister of Health), 2005 FC 189 ......................................................................................... 194, 199 AT v Globe24h.com, 2017 FC 114 .......................
  • Access to Information in the Public Sector
    • Canada
    • Irwin Books Information and Privacy Law in Canada
    • June 25, 2020
    ...at para 109, quoting from the Health Canada Guidelines referred to with approval in AstraZeneca Canada Inc v Canada (Minister of Health) , 2005 FC 189 at para 64 [ AstraZeneca ]. 334 Merck Frosst , above note 137 at para 116. 335 Ibid at para 118. 336 Ibid at para 122. See also AstraZeneca ......